Hachim Mahmood Yaseen, Alqutami Fatma, Hachim Ibrahim Yaseen, Heialy Saba Al, Busch Hauke, Hamoudi Rifat, Hamid Qutayba
College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.
Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates.
Life (Basel). 2022 Oct 8;12(10):1562. doi: 10.3390/life12101562.
Asthma is one of the most common and lifelong and chronic inflammatory diseases characterized by inflammation, bronchial hyperresponsiveness, and airway obstruction episodes. It is a heterogeneous disease of varying and overlapping phenotypes with many confounding factors playing a role in disease susceptibility and management. Such multifactorial disorders will benefit from using systems biology as a strategy to elucidate molecular insights from complex, quantitative, massive clinical, and biological data that will help to understand the underlying disease mechanism, early detection, and treatment planning. Systems biology is an approach that uses the comprehensive understanding of living systems through bioinformatics, mathematical, and computational techniques to model diverse high-throughput molecular, cellular, and the physiologic profiling of healthy and diseased populations to define biological processes. The use of systems biology has helped understand and enrich our knowledge of asthma heterogeneity and molecular basis; however, such methods have their limitations. The translational benefits of these studies are few, and it is recommended to reanalyze the different studies and omics in conjugation with one another which may help understand the reasons for this variation and help overcome the limitations of understanding the heterogeneity in asthma pathology. In this review, we aim to show the different factors that play a role in asthma heterogeneity and how systems biology may aid in understanding and deciphering the molecular basis of asthma.
哮喘是最常见的终身慢性炎症性疾病之一,其特征为炎症、支气管高反应性和气道阻塞发作。它是一种具有不同且重叠表型的异质性疾病,许多混杂因素在疾病易感性和管理中起作用。这种多因素疾病将受益于使用系统生物学作为一种策略,以从复杂、定量、大量的临床和生物学数据中阐明分子见解,这将有助于理解潜在的疾病机制、早期检测和治疗规划。系统生物学是一种通过生物信息学、数学和计算技术全面理解生命系统的方法,用于对健康和患病群体的各种高通量分子、细胞和生理特征进行建模,以定义生物过程。系统生物学的应用有助于理解和丰富我们对哮喘异质性和分子基础的认识;然而,这些方法有其局限性。这些研究的转化效益很少,建议相互结合重新分析不同的研究和组学,这可能有助于理解这种差异的原因,并有助于克服理解哮喘病理学异质性方面的局限性。在本综述中,我们旨在展示在哮喘异质性中起作用的不同因素,以及系统生物学如何有助于理解和解读哮喘的分子基础。